This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Clinical features

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

In Europe, boys are affected more frequently than girls, and the condition is usually apparent during the first year of life in more than 80 percent of patients (1).
The clinical triad of epiphora, blepharospasm and photophobia usually chracterise the disease (1)

  • epiphora is the earliest and most constant finding (although this scan be mistaken for congenital nasolacrimal duct obstruction and are often overlooked) (1)

Corneal clouding and ocular enlargement are the usual presenting symptoms (1). Increased ocular pressure is the cardinal sign.

Glaucomatous cupping of the optic disc occurs relatively early.

  • cup-to-disc ratio is increased (normal value in a healthy newborn is less than 0.3)
  • asymmetry in the cup to disc ratios (1)

Later findings include increased corneal diameter - above 11.5 mm is thought significant, epithelia oedema and increased depth of the anterior chamber. Corneal oedema disturbs the normal, bright lustre of the normal cornea, producing a "ground-glass" appearance. It is often accompanied by ruptures in the Descemet’s membrane (Haab striae) (1). The eye is buphthalmic.

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.